Document Detail


Treatment of graft-versus-host-disease with mesenchymal stromal cells.
MedLine Citation:
PMID:  21231805     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Mesenchymal stromal cells (MSC) are a population of phenotypically heterogeneous cells that can be isolated from many readily accessible tissues, including bone marrow, umbilical cord, placenta and adipose tissue, where they form part of the supportive, stromal micro-environment. Extensive ex vivo and pre-clinical data suggest that subpopulations within MSC contribute to immunomodulation of the host, without provoking immunologic responses from alloreactive T cells or other effector cells, as well as contributing to tissue repair. These unique properties make MSC an ideal investigational agent for treating graft-versus-host disease (GvHD). Therapeutic trials with varied MSC dosing schedules and clinical end-points have shown mixed results. We have reviewed the biology of MSC gleaned from pre-clinical models, and summarized the results of clinical trials utilizing MSC for the treatment of acute and chronic GvHD.
Authors:
Partow Kebriaei; Simon Robinson
Related Documents :
21505955 - A case of t cell prolymphocytic leukemia involving blast transformation.
16611855 - Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome prol...
21165555 - Mesenchymal stem cell-mediated t cell suppression occurs through secreted galectins.
21520405 - A geil flow cytometry consensus proposal for quantification of plasma cells: applicatio...
8747985 - The nebraska experience.
10433555 - Expression of scm-1alpha/lymphotactin and scm-1beta in natural killer cells is upregula...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-13
Journal Detail:
Title:  Cytotherapy     Volume:  -     ISSN:  1477-2566     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100895309     Medline TA:  Cytotherapy     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy...
Next Document:  A novel approach to measuring skin elasticity in systemic sclerosis: results from a pilot study.